DE602005011754D1 - Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren - Google Patents

Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren

Info

Publication number
DE602005011754D1
DE602005011754D1 DE602005011754T DE602005011754T DE602005011754D1 DE 602005011754 D1 DE602005011754 D1 DE 602005011754D1 DE 602005011754 T DE602005011754 T DE 602005011754T DE 602005011754 T DE602005011754 T DE 602005011754T DE 602005011754 D1 DE602005011754 D1 DE 602005011754D1
Authority
DE
Germany
Prior art keywords
nucleic acid
acid amplification
amplification process
novel nucleotide
nucleotide mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005011754T
Other languages
English (en)
Inventor
Brian Washburn
Douglas Lovern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Inc filed Critical Biomerieux Inc
Publication of DE602005011754D1 publication Critical patent/DE602005011754D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6846—Common amplification features
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
DE602005011754T 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren Active DE602005011754D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53881404P 2004-01-23 2004-01-23
US53881504P 2004-01-23 2004-01-23
US53881604P 2004-01-23 2004-01-23
PCT/US2005/002414 WO2005070027A2 (en) 2004-01-23 2005-01-21 A novel nucleotide mixture for improved nucleic acid amplification performance

Publications (1)

Publication Number Publication Date
DE602005011754D1 true DE602005011754D1 (de) 2009-01-29

Family

ID=34812082

Family Applications (3)

Application Number Title Priority Date Filing Date
DE602005011754T Active DE602005011754D1 (de) 2004-01-23 2005-01-21 Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren
DE602005025424T Active DE602005025424D1 (de) 2004-01-23 2005-01-21 Neuartiges Nukleotidgemisch für eine verbesserte Nukleinsäurenamplifikationsleistung
DE602005023586T Active DE602005023586D1 (de) 2004-01-23 2005-01-21 Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE602005025424T Active DE602005025424D1 (de) 2004-01-23 2005-01-21 Neuartiges Nukleotidgemisch für eine verbesserte Nukleinsäurenamplifikationsleistung
DE602005023586T Active DE602005023586D1 (de) 2004-01-23 2005-01-21 Primer- und sondenkonstruktion zur effizienten amplifikation und detektion des 3'-nichttranslatierten bereichs von hcv

Country Status (6)

Country Link
US (3) US20060003343A1 (de)
EP (3) EP1721015B1 (de)
JP (2) JP2007518425A (de)
AT (3) ATE417938T1 (de)
DE (3) DE602005011754D1 (de)
WO (2) WO2005070027A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080299568A1 (en) * 2007-04-27 2008-12-04 Scott Johnson Materials and methods for detection of hepatitis c virus
JP2009284896A (ja) * 2007-07-26 2009-12-10 Fujifilm Corp 核酸増幅方法
EP2058406A3 (de) * 2007-11-06 2009-10-28 Fujifilm Corporation RNA-Detektionsverfahren
EP2370601A1 (de) * 2008-12-31 2011-10-05 Abbott Laboratories Primer und sonden zum nachweis von hepatitis-c-virus

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09107970A (ja) * 1995-10-17 1997-04-28 Soyaku Gijutsu Kenkyusho:Kk Ｃ型肝炎ウイルス由来核酸、該核酸を用いたウイルスの検出方法
EP0052296B1 (de) * 1980-11-12 1984-06-27 Mitsubishi Kasei Corporation Als Heilmittel für Immunokrankheiten anwendbare Glutaminderivate, Verfahren zu deren Herstellung und Zusammensetzungen, die die obengenannten Derivate enthalten
US5087565A (en) * 1984-07-02 1992-02-11 Du Pont Merck Pharmaceutical Company Synthetic process for preparation of 32 P-labeled nucleotides
JPH0723393B2 (ja) * 1985-05-15 1995-03-15 アモコ・コーポレーション シチジン同族体
US4876187A (en) 1985-12-05 1989-10-24 Meiogenics, Inc. Nucleic acid compositions with scissile linkage useful for detecting nucleic acid sequences
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
IE72468B1 (en) 1987-07-31 1997-04-09 Univ Leland Stanford Junior Selective amplification of target polynucleotide sequences
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5030557A (en) 1987-11-24 1991-07-09 Ml Technology Venture Means and method for enhancing nucleic acid hybridization
JP2650159B2 (ja) 1988-02-24 1997-09-03 アクゾ・ノベル・エヌ・ベー 核酸増幅方法
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
DE69025958T2 (de) 1989-09-18 1996-11-14 Canon Kk Tintenstrahlaufzeichnungskopf und Tintenstrahlgerät mit diesem Kopf
ATE188509T1 (de) * 1990-02-16 2000-01-15 Hoffmann La Roche Verbesserungen in der spezifität und zweckmässigkeit der polymerase-kettenreaktion
AU681082B2 (en) 1992-05-06 1997-08-21 Gen-Probe Incorporated Nucleic acid sequence amplification method, composition and kit
US5648232A (en) * 1993-01-21 1997-07-15 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Microbiological best method and reagents
KR100238833B1 (ko) * 1994-03-10 2000-03-02 다니엘 엘. 캐시앙 이온성 세제에 의한 효소 개재 반응의 억제를 방지하는 방법
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
DE19612779A1 (de) * 1996-03-29 1997-10-02 Boehringer Mannheim Gmbh Verfahren zur spezifischen Vervielfältigung von langen Nukleinsäuren durch PCR
EP2264045B1 (de) * 1996-08-14 2015-10-21 Life Technologies Corporation Stabile Zusammensetzungen zur Amplifizierung und Sequenzierung von Nukleinsäuren
DE19647055A1 (de) * 1996-11-14 1998-05-20 Boehringer Mannheim Gmbh Stabilisierte wässrige Nukleosidtriphosphat-Lösungen
ATE486961T1 (de) 1997-04-03 2010-11-15 Life Technologies Corp Verfahren und produkte zur reversen transkription gekoppelt mit polymerasekettenreaktion (rt-pcr)
ZA989950B (en) * 1997-11-17 1999-05-04 Akzo Nobel Nv Transcription based amplification of double stranded DNA targets
AU757034B2 (en) * 1998-04-27 2003-01-30 Ribozyme Pharmaceuticals, Inc. Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
US6300075B1 (en) * 1999-02-03 2001-10-09 Ortho-Clinical Diagnostics, Inc Enhancement of the specificity of nucleic acid amplification by carrier nucleic acid
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
ATE362538T1 (de) * 1999-06-04 2007-06-15 Us Gov Health & Human Serv Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
US6271004B1 (en) * 1999-06-25 2001-08-07 Display Systems Biotech A/S Method for improved reverse transcription at high temperatures
EP1233976A4 (de) * 1999-11-17 2003-06-11 Jiuping Ji Simultaner nachweis von hbv, hcv und hiv in plasmaproben mit hilfe eines multiplexen fixierungstests
WO2001064959A1 (en) * 2000-03-02 2001-09-07 Akzo Nobel N.V. Detection of hepatitis b virus rna
JP2004532022A (ja) * 2001-03-26 2004-10-21 サーナ・セラピューティクス・インコーポレイテッド Ｂ型肝炎ウイルスおよびｃ型肝炎ウイルスの複製のオリゴヌクレオチド媒介性阻害
WO2003016572A1 (en) * 2001-08-17 2003-02-27 Eli Lilly And Company Oligonucleotide therapeutics for treating hepatitis c virus infections
US6783940B2 (en) * 2001-10-31 2004-08-31 Applera Corporation Method of reducing non-specific amplification in PCR
US6750009B2 (en) * 2002-01-29 2004-06-15 Apath, Llc Multiple viral replicon culture systems
WO2003100014A2 (en) * 2002-05-24 2003-12-04 Smithkline Beecham Corporation Method for quantitating negative strand rna synthesis

Also Published As

Publication number Publication date
WO2005071117A3 (en) 2006-04-20
EP2042612B1 (de) 2010-12-15
JP2007518424A (ja) 2007-07-12
JP4866248B2 (ja) 2012-02-01
US20060003343A1 (en) 2006-01-05
US7670779B2 (en) 2010-03-02
EP2042612A2 (de) 2009-04-01
US20080248480A1 (en) 2008-10-09
WO2005070027A2 (en) 2005-08-04
JP2007518425A (ja) 2007-07-12
US20060019266A1 (en) 2006-01-26
DE602005025424D1 (de) 2011-01-27
EP1721015A2 (de) 2006-11-15
US7364854B2 (en) 2008-04-29
EP2042612A3 (de) 2009-06-17
WO2005070027A3 (en) 2006-04-06
WO2005071117A2 (en) 2005-08-04
DE602005023586D1 (de) 2010-10-28
WO2005070027A8 (en) 2006-07-27
EP1706512A2 (de) 2006-10-04
ATE491810T1 (de) 2011-01-15
ATE481507T1 (de) 2010-10-15
EP1706512B1 (de) 2008-12-17
ATE417938T1 (de) 2009-01-15
EP1721015B1 (de) 2010-09-15

Similar Documents

Publication Publication Date Title
ATE550441T1 (de) Verfahren, zusammensetzungen und kits zur isothermischen amplifikation von nukleinsäuren
DE602005023588D1 (de) Verfahren zur genotypisierung von antigenen von blutzellen und ein kit zur genotypisierung
EP2272952B8 (de) Thermostabiler oder thermoactiver DNA-polymerase mit abgeschwächter 3'-5' Exonukleaseaktivität
DE602004021235D1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
WO2008051530A3 (en) Polymerase enzymes and reagents for enhanced nucleic acid sequencing
MY143596A (en) In vitro recombination method
WO2008033442A3 (en) Methods and compositions for performing low background multiplex nucleic acid amplification reactions
WO2009076485A3 (en) Sequencing of nucleic acids
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
DE112006002611A5 (de) Rna-abhängige rna-polymerase, verfahren und kits zur amplifikation und / oder markierung von rna
DE602005017252D1 (de) Verfahren zur amplifikation von nukleinsäuren mittels promotor-templates
SE0301951D0 (sv) New method
ATE417938T1 (de) Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren
DK1504098T3 (da) Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion
DE602008004702D1 (de) Verfahren zur Amplifikation von Nukleinsäure
WO2003004703A1 (en) Process for producing template dna and process for producing protein in cell-free protein synthesis system with the use of the same
ATE533847T1 (de) Verfahren für den nachweis und die quantifizierung einer endogenen dna-sequenz aus weizen
DE60331072D1 (de) Verfahren zur unspezifischen amplifizierung nukleinsäuren mit niedriger komplexität
WO2010039189A3 (en) Methods for sequencing degraded or modified nucleic acids
ATE399868T1 (de) Optimierte nukleotidsequenzen die für sgp130 kodieren
ATE420975T1 (de) Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren
ATE486138T1 (de) Verfahren zum nachweis von bakterien der gattung mycobacterium (säureresistente bakterien)
DE602004025815D1 (de) Verfahren zur amplifikation polymerer nukleinsäuren
RU2006134100A (ru) Способ проведения аллель-специфичной пцр для генотипирования крупного рогатого скота по аллелям а и в гена каппа-казеина
DE60334412D1 (de) Oligonukleotidprimer für das stn gen zur detektion von salmonella arten und entsprechende nachweismethoden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition